Home
About Us
Management Team
Scientific Advisory Board
Board of Directors
Science
Publications
Pipeline
Pipeline
Expanded Access
Investors & Media
Press Releases
Events & Presentations
Quarterly Results
SEC Filings
Governance
Analyst Coverage
ACHL Stock
Tax Information
IR Resources
Careers
Contact
Home
About Us
Management Team
Scientific Advisory Board
Board of Directors
Science
Publications
Pipeline
Pipeline
Expanded Access
Investors & Media
Press Releases
Events & Presentations
Quarterly Results
SEC Filings
Governance
Analyst Coverage
ACHL Stock
Tax Information
IR Resources
Careers
Contact
Contact Us
General Enquiries
info@achillestx.com
+44 (0)20 8154 4600
Please do not send any personal patient details in emails.
Investor Relations
ir@achillestx.com
Media Enquiries
media@achillestx.com
Achilles
Offices
UK Headquarters:
Achilles Therapeutics plc
245 Hammersmith Road
London
W6 8PW, UK
US Headquarters:
Achilles Therapeutics US, Inc.
401 N. Broad Street
Suite M121
Philadelphia, PA 19108
Additional UK Site:
Achilles Therapeutics plc
Stevenage Bioscience Catalyst
Gunnels Wood Road
Stevenage, Hertfordshire
SG1 2FX, UK
If you are a healthcare professional looking for information on our clinical trials and recruiting sites, please refer to
CHIRON: Patients With Advanced Unresectable or Metastatic NSCLC
or
THETIS: Patients With Metastatic or Recurrent Melanoma
on
www.clinicaltrials.gov.
